{"product_id":"ai-enabled-drug-discovery-and-clinical-trials-market-report-2023-2033","title":"AI-Enabled Drug Discovery and Clinical Trials Market Report 2023-2033","description":"\u003cp\u003eAI-Enabled Drug Discovery and Clinical Trials Market Report 2023-2033\u003c\/p\u003e\n\n\u003cp\u003eThe AI-Enabled Drug Discovery and Clinical Trials Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.\u003c\/p\u003e\n\n\u003cp\u003eGrowing Awareness of AI applications in Healthcare is Boosting the Market Growth\u003c\/p\u003e\n\n\u003cp\u003eWith the rise of AI applications in healthcare services, people’s awareness and acceptance of AI-enabled solutions have grown. More pharmaceutical companies are, therefore, seeking to incorporate these solutions into their drug discovery and clinical trial processes. AI-based drug delivery solutions are becoming increasingly popular in the pharmaceutical industry. These solutions involve using artificial intelligence technologies to develop more efficient and effective drug delivery methods. The use of AI in drug delivery has the potential to transform the industry by reducing costs, improving drug efficacy and safety, and providing better patient outcomes.\u003c\/p\u003e\n\n\u003cp\u003eThe market for AI-based drug delivery solutions is expected to grow in the coming years, with a number of companies already offering or developing such solutions. Some of the key players in this market include:\u003c\/p\u003e\n\n\u003cp\u003eNovartis - Novartis is one of the leading players in the AI-based drug delivery market, with a focus on developing smart inhalers to treat respiratory diseases.\u003c\/p\u003e\n\n\u003cp\u003eMedtronic - Medtronic is a medical devices company that is building an AI-based drug delivery platform to improve the delivery of insulin for diabetic patients.\u003c\/p\u003e\n\n\u003cp\u003eInsilico Medicine - Insilico Medicine is a drug discovery company that is using AI to develop new drugs and drug delivery methods.\u003c\/p\u003e\n\n\u003cp\u003eJohnson \u0026amp; Johnson - Johnson \u0026amp; Johnson is using AI to develop personalized drug delivery solutions, including smart drug-infused contact lenses and implantable drug delivery devices.\u003c\/p\u003e\n\n\u003cp\u003eGSK - GSK is using AI to develop inhalers that can adjust the dosage based on the patient's breathing pattern.\u003c\/p\u003e\n\n\u003cp\u003eAs the competition between market players intensifies, companies are investing heavily in research and development to stay ahead of the curve. This is driving innovation and pushing the boundaries of what is possible in the drug delivery industry. In the future, AI-based drug delivery solutions are likely to become increasingly sophisticated, personalized, and targeted, improving patient outcomes and transforming the pharmaceutical industry.\u003c\/p\u003e\n\n\u003cp\u003eLack of Skilled Personnel to Hinder the Market Growth\u003c\/p\u003e\n\n\u003cp\u003ePatient safety is a significant challenge during the drug discovery phase, as activities involving the interpretation of drug effects and anticipation of potential side effects can pose a major constraint on the market. Additionally, the lack of skilled personnel and inadequate datasets for drug discovery and development are crucial factors that may impact market growth. The implementation of AI systems in drug discovery requires companies to possess expertise in system design, management, and implementation. Given the complexity of AI, personnel working with these systems need to have a deep understanding of technologies such as machine learning, deep learning, and other aspects of artificial intelligence. Integrating AI technologies into existing systems to replicate human brain behaviour necessitates substantial data processing. AI\/ML development is being restricted owing to lack of professional standards and certifications.\u003c\/p\u003e\n\n\u003cp\u003eWhat Questions Should You Ask before Buying a Market Research Report?\u003c\/p\u003e\n\n\u003cp\u003eHow is the AI-enabled drug discovery and clinical trials market evolving?\u003c\/p\u003e\n\n\u003cp\u003eWhat is driving and restraining the AI-enabled drug discovery and clinical trials market?\u003c\/p\u003e\n\n\u003cp\u003eHow will each AI-enabled drug discovery and clinical trials submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?\u003c\/p\u003e\n\n\u003cp\u003eHow will the market shares for each AI-enabled drug discovery and clinical trials submarket develop from 2023 to 2033?\u003c\/p\u003e\n\n\u003cp\u003eWhat will be the main driver for the overall market from 2023 to 2033?\u003c\/p\u003e\n\n\u003cp\u003eWill leading AI-enabled drug discovery and clinical trials markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?\u003c\/p\u003e\n\n\u003cp\u003eHow will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?\u003c\/p\u003e\n\n\u003cp\u003eWho are the leading players and what are their prospects over the forecast period?\u003c\/p\u003e\n\n\u003cp\u003eWhat are the AI-enabled drug discovery and clinical trials projects for these leading companies?\u003c\/p\u003e\n\n\u003cp\u003eHow will the industry evolve during the period between 2023 and 2033? What are the implications of AI-enabled drug discovery and clinical trials projects taking place now and over the next 10 years?\u003c\/p\u003e\n\n\u003cp\u003eIs there a greater need for product commercialisation to further scale the AI-enabled drug discovery and clinical trials market?\u003c\/p\u003e\n\n\u003cp\u003eWhere is the AI-enabled drug discovery and clinical trials market heading and how can you ensure you are at the forefront of the market?\u003c\/p\u003e\n\n\u003cp\u003eWhat are the best investment options for new product and service lines?\u003c\/p\u003e\n\n\u003cp\u003eWhat are the key prospects for moving companies into a new growth path and C-suite?\u003c\/p\u003e\n\n\u003cp\u003eYou need to discover how this will impact the AI-enabled drug discovery and clinical trials market today, and over the next 10 years:\u003c\/p\u003e\n\n\u003cp\u003eOur 267-page report provides 102 tables and 151 charts\/graphs exclusively to you.\u003c\/p\u003e\n\n\u003cp\u003eThe report highlights key lucrative areas in the industry so you can target them – NOW.\u003c\/p\u003e\n\n\u003cp\u003eIt contains in-depth analysis of global, regional and national sales and growth.\u003c\/p\u003e\n\n\u003cp\u003eIt highlights for you the key successful trends, changes and revenue projections made by your competitors.\u003c\/p\u003e\n\n\u003cp\u003eThis report tells you TODAY how the AI-enabled drug discovery and clinical trials market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.\u003c\/p\u003e\n\n\u003cp\u003eForecasts to 2033 and other analyses reveal commercial prospects\u003c\/p\u003e\n\n\u003cp\u003eIn addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.\u003c\/p\u003e\n\n\u003cp\u003eYou will find original analyses, with business outlooks and developments.\u003c\/p\u003e\n\n\u003cp\u003eDiscover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising AI-enabled drug discovery and clinical trials prices and recent developments.\u003c\/p\u003e\n\n\u003cp\u003eThis report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.\u003c\/p\u003e\n\n\u003cp\u003eSegments Covered in the Report\u003c\/p\u003e\n\n\u003cp\u003eComponent Outlook\u003c\/p\u003e\n\n\u003cp\u003eServices\u003c\/p\u003e\n\n\u003cp\u003eSoftware\u003c\/p\u003e\n\n\u003cp\u003eApplication\u003c\/p\u003e\n\n\u003cp\u003eClinical Trials\u003c\/p\u003e\n\n\u003cp\u003eDrug Design\u003c\/p\u003e\n\n\u003cp\u003eData Aggregation and Analysis\u003c\/p\u003e\n\n\u003cp\u003eDrug Characterization\u003c\/p\u003e\n\n\u003cp\u003eBiomarker Research\u003c\/p\u003e\n\n\u003cp\u003eOthers\u003c\/p\u003e\n\n\u003cp\u003eTherapeutic Area\u003c\/p\u003e\n\n\u003cp\u003eOncology\u003c\/p\u003e\n\n\u003cp\u003eCardiovascular Diseases\u003c\/p\u003e\n\n\u003cp\u003eInfectious Diseases\u003c\/p\u003e\n\n\u003cp\u003eNeurodegenerative Diseases\u003c\/p\u003e\n\n\u003cp\u003eMetabolic Diseases\u003c\/p\u003e\n\n\u003cp\u003eOthers\u003c\/p\u003e\n\n\u003cp\u003eEnd-user\u003c\/p\u003e\n\n\u003cp\u003ePharmaceutical \u0026amp; Biopharmaceutical Companies\u003c\/p\u003e\n\n\u003cp\u003eContract Research Organizations (CROs)\u003c\/p\u003e\n\n\u003cp\u003eOthers\u003c\/p\u003e\n\n\u003cp\u003eIn addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 18 leading national markets:\u003c\/p\u003e\n\n\u003cp\u003eNorth America\u003c\/p\u003e\n\n\u003cp\u003eU.S.\u003c\/p\u003e\n\n\u003cp\u003eCanada\u003c\/p\u003e\n\n\u003cp\u003eEurope\u003c\/p\u003e\n\n\u003cp\u003eGermany\u003c\/p\u003e\n\n\u003cp\u003eUK\u003c\/p\u003e\n\n\u003cp\u003eFrance\u003c\/p\u003e\n\n\u003cp\u003eSpain\u003c\/p\u003e\n\n\u003cp\u003eItaly\u003c\/p\u003e\n\n\u003cp\u003eRussia\u003c\/p\u003e\n\n\u003cp\u003eRest of Europe\u003c\/p\u003e\n\n\u003cp\u003eAsia Pacific\u003c\/p\u003e\n\n\u003cp\u003eChina\u003c\/p\u003e\n\n\u003cp\u003eJapan\u003c\/p\u003e\n\n\u003cp\u003eIndia\u003c\/p\u003e\n\n\u003cp\u003eAustralia\u003c\/p\u003e\n\n\u003cp\u003eSouth Korea\u003c\/p\u003e\n\n\u003cp\u003eRest of Asia Pacific\u003c\/p\u003e\n\n\u003cp\u003eLatin America\u003c\/p\u003e\n\n\u003cp\u003eBrazil\u003c\/p\u003e\n\n\u003cp\u003eMexico\u003c\/p\u003e\n\n\u003cp\u003eArgentina\u003c\/p\u003e\n\n\u003cp\u003eRest of Latin America\u003c\/p\u003e\n\n\u003cp\u003eMEA\u003c\/p\u003e\n\n\u003cp\u003eGCC\u003c\/p\u003e\n\n\u003cp\u003eSouth Africa\u003c\/p\u003e\n\n\u003cp\u003eRest of MEA\u003c\/p\u003e\n\n\u003cp\u003eThe report also includes profiles and for some of the leading companies in the AI-Enabled Drug Discovery and Clinical Trials Market, 2023 to 2033, with a focus on this segment of these companies’ operations.\u003c\/p\u003e\n\n\u003cp\u003eLeading companies and the potential for market growth\u003c\/p\u003e\n\n\u003cp\u003eAbbVie Inc.\u003c\/p\u003e\n\n\u003cp\u003eExscientia\u003c\/p\u003e\n\n\u003cp\u003eGNS Healthcare\u003c\/p\u003e\n\n\u003cp\u003eIBM Watson\u003c\/p\u003e\n\n\u003cp\u003eMerck \u0026amp; Co., Inc.\u003c\/p\u003e\n\n\u003cp\u003eNovartis AG\u003c\/p\u003e\n\n\u003cp\u003ePathAI\u003c\/p\u003e\n\n\u003cp\u003eSaama Technologies\u003c\/p\u003e\n\n\u003cp\u003eUnlearn.AI, Inc.\u003c\/p\u003e\n\n\u003cp\u003eOverall world revenue for AI-Enabled Drug Discovery and Clinical Trials Market, 2023 to 2033 in terms of value the market will surpass US$2,156.8 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.\u003c\/p\u003e\n\n\u003cp\u003eHow will the AI-Enabled Drug Discovery and Clinical Trials Market, 2023 to 2033 report help you?\u003c\/p\u003e\n\n\u003cp\u003eIn summary, our 260+ page report provides you with the following knowledge:\u003c\/p\u003e\n\n\u003cp\u003eRevenue forecasts to 2033 for AI-Enabled Drug Discovery and Clinical Trials Market, 2023 to 2033 Market, with forecasts for component, application, therapeutic area, and end-user, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.\u003c\/p\u003e\n\n\u003cp\u003eRevenue forecasts to 2033 for five regional and 18 key national markets – See forecasts for the AI-Enabled Drug Discovery and Clinical Trials Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.\u003c\/p\u003e\n\n\u003cp\u003eProspects for established firms and those seeking to enter the market – including company profiles for 9 of the major companies involved in the AI-Enabled Drug Discovery and Clinical Trials Market, 2023 to 2033.\u003c\/p\u003e\n\n\u003cp\u003eFind quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.\u003c\/p\u003e\n\n\u003cp\u003eInformation found nowhere else\u003c\/p\u003e\n\n\u003cp\u003eWith our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the AI-Enabled Drug Discovery and Clinical Trials Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.\u003c\/p\u003e\n\n\u003cp\u003ePlease Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher..\u003c\/p\u003e\n\n\u003cp\u003eThe publisher is using a password system to access single user and team licenses. Single user (non-printable) and team licenses expire after 12 month period. In the case of team license purchases, the publisher requires all email addresses for the licensed users prior to fulfilment.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"June, 2023 \/ 267 Pages \/ MCW16230924","offer_id":47647231902002,"sku":null,"price":5926.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/ai-enabled-drug-discovery-and-clinical-trials-market-report-2023-2033","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}